223 related articles for article (PubMed ID: 22951291)
1. The activities of 5α-reductase and 17,20-lyase determine the direction through androgen synthesis pathways in patients with 21-hydroxylase deficiency.
Kamrath C; Hartmann MF; Remer T; Wudy SA
Steroids; 2012 Nov; 77(13):1391-7. PubMed ID: 22951291
[TBL] [Abstract][Full Text] [Related]
2. Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis.
Kamrath C; Hochberg Z; Hartmann MF; Remer T; Wudy SA
J Clin Endocrinol Metab; 2012 Mar; 97(3):E367-75. PubMed ID: 22170725
[TBL] [Abstract][Full Text] [Related]
3. CYP17A1 exhibits 17αhydroxylase/17,20-lyase activity towards 11β-hydroxyprogesterone and 11-ketoprogesterone metabolites in the C11-oxy backdoor pathway.
van Rooyen D; Yadav R; Scott EE; Swart AC
J Steroid Biochem Mol Biol; 2020 May; 199():105614. PubMed ID: 32007561
[TBL] [Abstract][Full Text] [Related]
4. Androgen synthesis in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Kamrath C; Hartmann MF; Wudy SA
Horm Metab Res; 2013 Feb; 45(2):86-91. PubMed ID: 23345132
[TBL] [Abstract][Full Text] [Related]
5. Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone.
Homma K; Hasegawa T; Nagai T; Adachi M; Horikawa R; Fujiwara I; Tajima T; Takeda R; Fukami M; Ogata T
J Clin Endocrinol Metab; 2006 Jul; 91(7):2643-9. PubMed ID: 16608896
[TBL] [Abstract][Full Text] [Related]
6. Androgen biosynthesis during minipuberty favors the backdoor pathway over the classic pathway: Insights into enzyme activities and steroid fluxes in healthy infants during the first year of life from the urinary steroid metabolome.
Dhayat NA; Dick B; Frey BM; d'Uscio CH; Vogt B; Flück CE
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):312-322. PubMed ID: 27471148
[TBL] [Abstract][Full Text] [Related]
7. The in vitro metabolism of 11β-hydroxyprogesterone and 11-ketoprogesterone to 11-ketodihydrotestosterone in the backdoor pathway.
van Rooyen D; Gent R; Barnard L; Swart AC
J Steroid Biochem Mol Biol; 2018 Apr; 178():203-212. PubMed ID: 29277707
[TBL] [Abstract][Full Text] [Related]
8. Assessment of steroidogenesis and steroidogenic enzyme functions.
Luu-The V
J Steroid Biochem Mol Biol; 2013 Sep; 137():176-82. PubMed ID: 23770321
[TBL] [Abstract][Full Text] [Related]
9. Non-Classic Disorder of Adrenal Steroidogenesis and Clinical Dilemmas in 21-Hydroxylase Deficiency Combined with Backdoor Androgen Pathway. Mini-Review and Case Report.
Sumińska M; Bogusz-Górna K; Wegner D; Fichna M
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610579
[TBL] [Abstract][Full Text] [Related]
10. 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro.
Gent R; du Toit T; Swart AC
J Steroid Biochem Mol Biol; 2019 Jul; 191():105369. PubMed ID: 31039398
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of androgen synthesis via 5alpha-reduced precursors.
Ghayee HK; Auchus RJ
Endocr Dev; 2008; 13():55-66. PubMed ID: 18493133
[TBL] [Abstract][Full Text] [Related]
12. Adrenal C11-oxy C
Barnard L; Gent R; van Rooyen D; Swart AC
J Steroid Biochem Mol Biol; 2017 Nov; 174():86-95. PubMed ID: 28774496
[TBL] [Abstract][Full Text] [Related]
13. 5alpha-reduced C21 steroids are substrates for human cytochrome P450c17.
Gupta MK; Guryev OL; Auchus RJ
Arch Biochem Biophys; 2003 Oct; 418(2):151-60. PubMed ID: 14522586
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
[TBL] [Abstract][Full Text] [Related]
15. Metabolic evidence for impaired 17alpha-hydroxylase activity in a kindred bearing the E305G mutation for isolate 17,20-lyase activity.
Tiosano D; Knopf C; Koren I; Levanon N; Hartmann MF; Hochberg Z; Wudy SA
Eur J Endocrinol; 2008 Mar; 158(3):385-92. PubMed ID: 18299473
[TBL] [Abstract][Full Text] [Related]
16. Alternative (backdoor) androgen production and masculinization in the human fetus.
O'Shaughnessy PJ; Antignac JP; Le Bizec B; Morvan ML; Svechnikov K; Söder O; Savchuk I; Monteiro A; Soffientini U; Johnston ZC; Bellingham M; Hough D; Walker N; Filis P; Fowler PA
PLoS Biol; 2019 Feb; 17(2):e3000002. PubMed ID: 30763313
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer.
Attard G; Reid AH; Auchus RJ; Hughes BA; Cassidy AM; Thompson E; Oommen NB; Folkerd E; Dowsett M; Arlt W; de Bono JS
J Clin Endocrinol Metab; 2012 Feb; 97(2):507-16. PubMed ID: 22170708
[TBL] [Abstract][Full Text] [Related]
18. Partial deficiency of 17α-hydroxylase/17,20-lyase caused by a novel missense mutation in the canonical cytochrome heme-interacting motif.
Rubtsov P; Nizhnik A; Dedov I; Kalinchenko N; Petrov V; Orekhova A; Spirin P; Prassolov V; Tiulpakov A
Eur J Endocrinol; 2015 May; 172(5):K19-25. PubMed ID: 25650406
[TBL] [Abstract][Full Text] [Related]
19. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
20. A review of the literature on common CYP17A1 mutations in adults with 17-hydroxylase/17,20-lyase deficiency, a case series of such mutations among Koreans and functional characteristics of a novel mutation.
Kim YM; Kang M; Choi JH; Lee BH; Kim GH; Ohn JH; Kim SY; Park MS; Yoo HW
Metabolism; 2014 Jan; 63(1):42-9. PubMed ID: 24140098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
